{"transactions":[{"id":680702,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-08-20T21:02:57.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":69252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive the economic equivalent of one share of common stock of Interpace Biosciences, Inc."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on August 20, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":69252,"derivative":{"underlying":"Common Stock","underlying_shares":69252},"source":{"system":"sec-edgar","filing":"0001493152-26-039504","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315226039504/ownership.xml","form_type":"4"}},{"id":1010197,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-11-03T22:37:56.000Z","date":"2025-10-30","kind":"grant","planned":false,"acquired":true,"shares":3777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders."}],"balance_after":3777,"derivative":{"exercise_price":60.96,"expiration_date":"2035-10-30","underlying":"Common Stock","underlying_shares":3777},"source":{"system":"sec-edgar","filing":"0000914190-25-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419025000024/form4.xml","form_type":"4"}},{"id":1010196,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-03T22:37:56.000Z","date":"2025-10-30","kind":"grant","planned":false,"acquired":true,"shares":1640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15411,"source":{"system":"sec-edgar","filing":"0000914190-25-000024","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419025000024/form4.xml","form_type":"4"}},{"id":1380916,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2024-10-28T20:44:13.000Z","date":"2024-10-24","kind":"grant","planned":false,"acquired":true,"shares":3511,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders."}],"balance_after":3511,"derivative":{"exercise_price":68.37,"expiration_date":"2034-10-24","underlying":"Common Stock","underlying_shares":3511},"source":{"system":"sec-edgar","filing":"0001062993-24-018034","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324018034/form4.xml","form_type":"4"}},{"id":1380915,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-28T20:44:13.000Z","date":"2024-10-24","kind":"grant","planned":false,"acquired":true,"shares":1462,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13771,"source":{"system":"sec-edgar","filing":"0001062993-24-018034","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299324018034/form4.xml","form_type":"4"}},{"id":1754063,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2023-10-30T20:42:54.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":3937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders."}],"balance_after":3937,"derivative":{"exercise_price":61.51,"expiration_date":"2033-10-26","underlying":"Common Stock","underlying_shares":3937},"source":{"system":"sec-edgar","filing":"0001062993-23-019848","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323019848/form4.xml","form_type":"4"}},{"id":1754062,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-30T20:42:54.000Z","date":"2023-10-26","kind":"grant","planned":false,"acquired":true,"shares":1625,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12309,"source":{"system":"sec-edgar","filing":"0001062993-23-019848","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000106299323019848/form4.xml","form_type":"4"}},{"id":2130077,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-31T21:19:50.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders."}],"balance_after":865,"derivative":{"exercise_price":295.77,"expiration_date":"2032-10-27","underlying":"Common Stock","underlying_shares":865},"source":{"system":"sec-edgar","filing":"0001415889-22-010914","document":"form4-10312022_021040.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922010914/form4-10312022_021040.xml","form_type":"4"}},{"id":2130076,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-31T21:19:50.000Z","date":"2022-10-27","kind":"grant","acquired":true,"shares":338,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2671,"source":{"system":"sec-edgar","filing":"0001415889-22-010914","document":"form4-10312022_021040.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000141588922010914/form4-10312022_021040.xml","form_type":"4"}},{"id":2531236,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-11-01T20:37:53.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/28/21) or the date of Bio-Techne's 2022 annual meeting of shareholders."}],"balance_after":633,"derivative":{"exercise_price":515.24,"expiration_date":"2031-10-28","underlying":"Common Stock","underlying_shares":633},"source":{"system":"sec-edgar","filing":"0000914190-21-000397","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000397/edgar.xml","form_type":"4"}},{"id":2531235,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-11-01T20:37:53.000Z","date":"2021-10-28","kind":"grant","acquired":true,"shares":194,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2333,"source":{"system":"sec-edgar","filing":"0000914190-21-000397","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000091419021000397/edgar.xml","form_type":"4"}},{"id":2996903,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-02T20:17:02.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":1507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne's 2021 annual meeting of shareholders."}],"balance_after":1507,"derivative":{"exercise_price":255.69,"expiration_date":"2030-10-29","underlying":"Common Stock","underlying_shares":1507},"source":{"system":"sec-edgar","filing":"0001562180-20-006491","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006491/primarydocument.xml","form_type":"4"}},{"id":2996902,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-11-02T20:17:02.000Z","date":"2020-10-29","kind":"grant","acquired":true,"shares":391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2139,"source":{"system":"sec-edgar","filing":"0001562180-20-006491","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218020006491/primarydocument.xml","form_type":"4"}},{"id":3085387,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-10T23:58:28.000Z","date":"2020-07-09","kind":"grant","acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is eligible to vest in equal installments on each of the first three anniversaries of the date of grant."}],"balance_after":29000,"derivative":{"exercise_price":5.21,"expiration_date":"2030-07-08","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001493152-20-013113","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315220013113/ownership.xml","form_type":"4"}},{"id":3387387,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-10-28T21:06:12.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":2011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne's 2020 annual meeting of shareholders."}],"balance_after":2011,"derivative":{"exercise_price":201.64,"expiration_date":"2029-10-24","underlying":"Common Stock","underlying_shares":2011},"source":{"system":"sec-edgar","filing":"0001624404-19-000016","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/842023/000162440419000016/edgar.xml","form_type":"4"}},{"id":3387386,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-28T21:06:12.000Z","date":"2019-10-24","kind":"grant","acquired":true,"shares":495,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1748,"source":{"system":"sec-edgar","filing":"0001624404-19-000016","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000162440419000016/edgar.xml","form_type":"4"}},{"id":3781896,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2018-10-29T20:57:40.000Z","date":"2018-10-25","kind":"grant","acquired":true,"shares":1898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option vests on the earlier of the one year anniversary of the grant date (10/25/2019) or the date of Bio-Techne 2019 Annual Meeting of Shareholders."}],"balance_after":1898,"derivative":{"exercise_price":179.84,"expiration_date":"2028-10-25","underlying":"Common Stock","underlying_shares":1898},"source":{"system":"sec-edgar","filing":"0001562180-18-004305","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018004305/primarydocument.xml","form_type":"4"}},{"id":3781895,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-29T20:57:40.000Z","date":"2018-10-25","kind":"grant","acquired":true,"shares":514,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1253,"source":{"system":"sec-edgar","filing":"0001562180-18-004305","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218018004305/primarydocument.xml","form_type":"4"}},{"id":4004688,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-03-09T22:31:24.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":19200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option award vests and becomes exercisable over a three-year period, in equal installments, commencing on March 7, 2019, subject to the reporting person's continued service with the Issuer."}],"balance_after":19200,"derivative":{"exercise_price":1.01,"expiration_date":"2018-03-07","underlying":"Common Stock","underlying_shares":19200},"source":{"system":"sec-edgar","filing":"0001493152-18-003191","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315218003191/form4.xml","form_type":"4"}},{"id":4004687,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-09T22:31:24.000Z","date":"2018-03-07","kind":"grant","acquired":true,"shares":4800,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted units vest annually, in equal installments, over a three-year period, commencing on March 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted unit represents the contingent right to receive one share of common stock of Interpace Diagnostics Group, Inc. (the \"Issuer\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects 1-for-10 reverse stock split, effective as of December 28, 2016."}],"balance_after":17569,"source":{"system":"sec-edgar","filing":"0001493152-18-003191","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315218003191/form4.xml","form_type":"4"}},{"id":4177882,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2017-10-31T15:37:16.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":3125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of the one year anniversary of the grant date (10/26/2017) or the date of Bio-Techne 2018 annual meeting of shareholders."}],"balance_after":3125,"derivative":{"exercise_price":125.05,"expiration_date":"2027-10-26","underlying":"Common Stock","underlying_shares":3125},"source":{"system":"sec-edgar","filing":"0001562180-17-003392","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003392/primarydocument.xml","form_type":"4"}},{"id":4177881,"issuer":{"id":3479,"kind":"organization","name":"BIO-TECHNE Corp","symbol":"TECH"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-31T15:37:16.000Z","date":"2017-10-26","kind":"grant","acquired":true,"shares":739,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":739,"source":{"system":"sec-edgar","filing":"0001562180-17-003392","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/842023/000156218017003392/primarydocument.xml","form_type":"4"}},{"id":4202125,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-09-26T21:26:59.000Z","date":"2017-09-25","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award vests and becomes exercisable over a one-year period, in twelve equal installments, subject to the reporting person's continued service with the issuer."}],"balance_after":10000,"derivative":{"exercise_price":1.48,"expiration_date":"2018-09-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001493152-17-010935","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000149315217010935/form4.xml","form_type":"4"}},{"id":4381588,"issuer":{"id":7296,"kind":"organization","name":"INTERPACE BIOSCIENCES, INC."},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-03-17T20:06:49.000Z","date":"2017-03-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award vests and becomes exercisable over a one-year period, commencing on March 15, 2017, in twelve equal installments, on the 14th day of each calendar month, subject to the reporting person's continued service with the issuer."}],"balance_after":10000,"derivative":{"exercise_price":2.18,"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001192482-17-000073","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1054102/000119248217000073/edgar.xml","form_type":"4"}},{"id":4537948,"issuer":{"id":180768,"kind":"organization","name":"RESPONSE BIOMEDICAL CORP","symbol":"RBM"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T21:11:20.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prices shown are denominated in Canadian dollars."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the Arrangement, all outstanding options to purchase common shares of the issuer as of immediately prior to the effective time of the Arrangement, were deemed  unconditionally vested and exercisable, and subsequently cancelled in exchange for cash payment equal to the difference between the per share consideration of $1.12 CDN and the per share exercise price of such option multiplied by the number of  common shares issuable pursuant to such option, less applicable withholdings."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Subject to the reporting person's continued service as a director of the company through each vesting date, 100% of the shares subject to the option shall vest and become exercisable on March 24, 2017."}],"balance_after":0,"derivative":{"exercise_price":0.85,"expiration_date":"2026-03-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-16-042842","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/806888/000143774916042842/rdgdoc.xml","form_type":"4"}},{"id":4537947,"issuer":{"id":180768,"kind":"organization","name":"RESPONSE BIOMEDICAL CORP","symbol":"RBM"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T21:11:20.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prices shown are denominated in Canadian dollars."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with the Arrangement, all outstanding options to purchase common shares of the issuer as of immediately prior to the effective time of the Arrangement, were deemed  unconditionally vested and exercisable, and subsequently cancelled in exchange for cash payment equal to the difference between the per share consideration of $1.12 CDN and the per share exercise price of such option multiplied by the number of  common shares issuable pursuant to such option, less applicable withholdings."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the options vest on March 20, 2016, subject to the reporting person's continued service as a director of the Company through each vesting date."}],"balance_after":0,"derivative":{"exercise_price":0.92,"expiration_date":"2025-03-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-16-042842","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/806888/000143774916042842/rdgdoc.xml","form_type":"4"}},{"id":4537946,"issuer":{"id":180768,"kind":"organization","name":"RESPONSE BIOMEDICAL CORP","symbol":"RBM"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T21:11:20.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prices shown are denominated in Canadian dollars."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Arrangement, out of money stock options were cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the options vest fully on the date which is one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":1.43,"expiration_date":"2024-03-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-16-042842","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/806888/000143774916042842/rdgdoc.xml","form_type":"4"}},{"id":4537945,"issuer":{"id":180768,"kind":"organization","name":"RESPONSE BIOMEDICAL CORP","symbol":"RBM"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T21:11:20.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prices shown are denominated in Canadian dollars."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Arrangement, out of money stock options were cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the options vest fully on the date which is one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":3.1,"expiration_date":"2023-03-14","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-16-042842","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/806888/000143774916042842/rdgdoc.xml","form_type":"4"}},{"id":4537944,"issuer":{"id":180768,"kind":"organization","name":"RESPONSE BIOMEDICAL CORP","symbol":"RBM"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2016-12-01T21:11:20.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Prices shown are denominated in Canadian dollars."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Pursuant to the terms of the Arrangement, out of money stock options were cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"100% of the options vest fully on the date which is one year after the date of grant."}],"balance_after":0,"derivative":{"exercise_price":2.2,"expiration_date":"2022-04-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001437749-16-042842","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/806888/000143774916042842/rdgdoc.xml","form_type":"4"}},{"id":4537943,"issuer":{"id":180768,"kind":"organization","name":"RESPONSE BIOMEDICAL CORP","symbol":"RBM"},"owners":[{"id":21451,"kind":"person","name":"KEEGAN JOSEPH D","position":1,"cik":"0001260556","reported_name":"KEEGAN JOSEPH D","relationship":{"director":true}}],"security":"Common Stock","published_at":"2016-12-01T21:11:20.000Z","date":"2016-11-29","kind":"disposition_to_issuer","acquired":false,"shares":73850,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Arrangement by and between the issuer and 1077801 B.C. Ltd., dated June 16, 2016 (the \"Arrangement\"), pursuant to which 1077801 B.C. Ltd. acquired all of the outstanding common shares of the issuer (other than those rolled over into the purchaser) in exchange for cash consideration of $1.12 CDN per share."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-16-042842","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/806888/000143774916042842/rdgdoc.xml","form_type":"4"}}]}